Swiss Federal Institute of Technology   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4
Founded: Lausanne Switzerland (1853)

Organization Overview

First Clinical Trial
2003
NCT00174902
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Bryn Lloyd | CIP-International Potato Center | ETH | ETH Zuerich | ETH Zurich | ETH Zurich, Switzerland | Exercise Physiology Lab, Institute of Human Movement Sciences and Sport, ETH Zurich | Human Nutrition Laboratory, ETH Zuerich | Human Nutrition Laboratory, ETH Zurich | INN | Institute for Biomedical Engineering, Swiss Federal Institute of Technology (ETH Zurich) | International Potato Center | Isabelle Herter-Aeberli | Laboratory of Human Nutrition ETH Zürich | Military Academy at ETH Zurich | Nicole Stoffel | Professor and Head, Human Nutrition, Swiss Federal Institute of Technology (ETH) Zurich, Switzerland | Prof. Michael B. Zimmermann | Swiss Federal Institute of Technology | Swiss Federal Institute of Technology (ETH) | Swiss Federal Institute of Technology (ETH,Zurich) | Swiss Federal Institute of Technology (ETH) Zurich | Swiss Federal Institute of Technology (ETH Zürich) | Swiss Federal Institute of Technology, ETH Zurich, Switzerland | Swiss Federal Institute of Technology, Institute of Behavioral Sciences | Swiss Federal Institute of Technology in Zurich (ETHZ) | Swiss Federal Institute of Technology Zurich | Women's clinc University Hospital Zurich

Active Ingredients

Drugs in Phase 4 Trials (1)

acetylcysteine (mucomyst) (1 trial)

Drugs in Phase 2 Trials (4)

acetylsalicylic acid (aspirin) (1 trial)

potassium chloride (klor-con) (1 trial)

potassium citrate (urocit-k) (1 trial)

propranolol (inderal) (1 trial)

Drugs in Phase 1 Trials (6)

benserazide (1 trial)

dextrose (1 trial)

iron (11 trials)

levodopa (larodopa) (1 trial)

vitamin a (2 trials)

zinc (3 trials)

Drugs in Other Trials (39)

alpha-galacto-oligosaccharides (2 trials)

amodiaquine (camoquin) (1 trial)

bovine lactoferrin (1 trial)

ferric ammonium citrate (Ferriseltz) (1 trial)

ferric carboxymaltose (Injectafer) (2 trials)

ferric phosphate (1 trial)

ferric pyrophosphate citrate (Triferic) (3 trials)

ferric sulfate (5 trials)

ferrous bisglycinate (1 trial)

ferrous sulfate (13 trials)

fish oil (Omegavan) (1 trial)

fumaric acid esters (9 trials)

galactooligosaccharide (4 trials)

hyaluronic acid (1 trial)

ibuprofen (motrin) (1 trial)

icosapent ethyl (vascepa) (1 trial)

inulin (1 trial)

iodine (2 trials)

iodized oil (2 trials)

iron sulfate (10 trials)

lactobacillus rhamnosus (1 trial)

lactoferrin (2 trials)

lactulose (cephulac) (1 trial)

maltodextrin (2 trials)

multivitamins (2 trials)

oligofructose-enriched inulin (1 trial)

omega-3 fatty acids (Omacor) (2 trials)

ovotransferrin (1 trial)

potato (1 trial)

pyrimethamine (daraprim) (1 trial)

sodium bicarbonate (1 trial)

sodium feredetate (1 trial)

sodium iron chlorophyllin (2 trials)

sucrose (1 trial)

sulfadoxine (1 trial)

tea (1 trial)

vitamin c (5 trials)

vitamin e (1 trial)

zinc dichloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acidosis (Phase 2)

Arteriosclerosis (Phase 2)

Behavior, Addictive (Phase 4)

Bone Diseases (Phase 2)

Cocaine-Related Disorders (Phase 4)

Night Blindness (Phase 1)

Schizotypal Personality Disorder (Phase 1)

Stress, Psychological (Phase 2)

Vitamin A Deficiency (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 63
  • # of Trial APIs: 50